DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Referenz

Liu G, Wilding G, Staab MJ, Horvath D, Miller K, Dresen A, Alberti D, Arzoomanian R, Chappell R, Bailey HH.
Phase II study of 1α-hydroxyvitamin D2 in the treatment of advanced androgen-independent prostate cancer.

Clin Cancer Res 2003;
9: 4077-4083

Bibliographische Angaben herunterladen

Aufrufen in: